Mission
Lacto Therapeutics is focused on the development of innovative antioxidant-based solutions for complex clinical conditions. Our mission is to advance therapeutic approaches for the prevention and management of postoperative complications in cancer care—particularly those associated with oxidative stress, endotoxemia, and systemic inflammation.
Scientific focus
Advances in biomedical research highlight the oxidative–antioxidant system as a critical component of physiological homeostasis and a relevant factor across multiple disease pathways. In oncology, activation of oxidative processes is relevant not only for tumor biology, but also for treatment-related complications.
Surgical interventions, chemotherapy, radiation therapy, anesthesia, and blood loss can significantly increase oxidative burden. In susceptible patients, this may strain endogenous antioxidant defenses and contribute to secondary complications.
The clinical challenge
Oncological surgeries are often extensive and traumatic, frequently accompanied by significant blood loss and combined treatment modalities. These factors can intensify lipid peroxidation, disrupt redox balance, and contribute to oxidative stress that may not be subject to spontaneous correction.
Under these conditions, patients may face increased risk of severe postoperative complications, including multiple organ dysfunction and purulent-septic processes, which can be associated with substantial morbidity and mortality.
Why antioxidant therapy matters
Despite the recognized role of oxidative stress in postoperative and septic complications, clinical approaches often prioritize antibacterial and detoxification strategies. Correction of oxidative imbalance is frequently under-addressed, particularly in patients with pre-existing impairment of antioxidant protection.
Effective antioxidant therapy requires agents whose activity corresponds to the depth of oxidative–antioxidant imbalance. Conventional approaches may be insufficient in scenarios involving severe oxidative disturbances.
Our approach
Lacto Therapeutics is developing an antioxidant-based therapeutic strategy centered on biologically active molecules with multifunctional properties. A key area of interest is lactoferrin, a naturally occurring iron-binding glycoprotein present in human secretions and neutrophils.
Lactoferrin is described in the literature as exhibiting antioxidant, immunomodulatory, and antimicrobial properties. Physiological demand for lactoferrin may increase under conditions associated with severe infection and endotoxicosis, where endogenous mechanisms may be insufficient.
By integrating advances in redox biology and translational research, we aim to address oxidative stress as a core mechanism underlying postoperative complications in cancer care.
Vision
We believe that restoring oxidative–antioxidant balance is a meaningful step toward improving outcomes in complex surgical and oncological care. Our long-term goal is to contribute to safer postoperative recovery, reduced complication rates, and improved quality of life through scientifically grounded antioxidant strategies.